Among the many recommendations for the treatment of alcohol use disorder, the APA recommends the following:
The initial goals of treatment should include discussion of the patient's legal obligations (eg, abstinence from alcohol use, monitoring of abstinence). These should be documented in the medical record
Patients with alcohol use disorder should have a documented and individualized treatment plan that includes evidence-based nonpharmacologic and pharmacologic treatments
Antidepressant medications should not be used for the treatment of alcohol use disorder unless a comorbid disorder is present for which an antidepressant is an indicated treatment
Benzodiazepines should not be used unless treating acute alcohol withdrawal or a comorbid disorder is present for which a benzodiazepine is an indicated treatment
Naltrexone or acamprosate should be offered to patients with moderate-to-severe alcohol use disorder; disulfiram, topiramate, or gabapentin is recommended for patients who prefer these medications or those who have not responded to treatment with naltrexone and acamprosate; acamprosate should not be used by patients who have severe renal impairment and should not be used as a first-line treatment in those with mild-to-moderate renal impairment
Naltrexone is recommended in patients with alcohol use disorder and comorbid opioid use disorder, if patients wish to abstain from opioid use and either abstain from or reduce alcohol use and are able to abstain from opioid use for a clinically appropriate time prior to naltrexone initiation
For more on the treatment of alcohol use disorder, read here.
Medscape © 2019 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Stephen Soreff. Fast Five Quiz: Alcohol Use and Abuse - Medscape - Jan 03, 2019.